Moleculin Doses First EU Patient in Phase 3 Pivotal MIRACLE Trial for Treatment of Acute Myeloid Leukemia
Provided By GlobeNewswire
Last update: Sep 8, 2025
Spain site opens with two R/R AML subjects enrolled; One treated
On track to recruit 45 subjects in 4Q25 for initial data unblinding
Read more at globenewswire.com
